Latest 10-Q quarterly reports

NYSE
Tronox Holdings PLC announced its second quarter 2026 financial results, reporting a wider net loss and decreased gross profit margin, impacted by higher costs and a significant tax valuation allowance.
NYSE
Ralph Lauren Corporation announced a significant increase in net revenues and net income for the first quarter ended June 27, 2026, driven by broad segment growth and improved gross margins.
USA TODAY Co. reported a decrease in total revenues for the second quarter of 2026, driven by declines in print and commercial segments, though digital revenue saw a slight increase.
AMEX
Mastech Digital, Inc. filed its Q2 2026 10-Q, reporting a year-over-year revenue decrease of 15.6% and a net loss for the quarter.
NASDAQ
Warner Bros. Discovery reported a challenging Q2 2026 with declines in advertising and content revenue, alongside a significant Netflix termination fee, impacting overall financial performance.
NASDAQ
The York Water Company announced significant year-over-year increases in revenue and net income for the second quarter of 2026, driven by rate adjustments and customer base expansion.
NYSE
Deluxe Corporation's Q2 2026 Form 10-Q details a strategic acquisition of Celero Commerce, mixed revenue performance with growth in payments and data solutions offset by declines in Print, and improved operational efficiencies.
NASDAQ
Victory Capital Holdings announced a substantial increase in revenue and net income for the second quarter of 2026, driven by a significant rise in assets under management and improved operational efficiencies.
NYSE
Watts Water Technologies announced significant Q2 2026 results, with net sales up 18.6% and operating income rising 13.8%, driven by price realization, volume, and strategic acquisitions.
NYSE
Marriott Vacations Worldwide Corporation announced its financial results for the second quarter and first half of 2026, showcasing revenue growth and increased contract sales.
GPGI, Inc. files its Q2 2026 10-Q, detailing financial performance, strategic updates following the Husky acquisition, and ongoing operational adjustments.
NYSE
Silgan Holdings reported a 6.8% increase in Q2 2026 net sales to $1.6 billion, driven by cost pass-throughs and favorable currency, but saw a decline in income before interest and taxes and adjusted EBIT.
NASDAQ
Neostellar Capital Corp. (formerly SuRo Capital Corp.) reported a significant increase in operating expenses and a net investment loss for the six months ended June 30, 2026, largely due to costs associated with its transition to an externally managed BDC.
NASDAQ
Iovance Biotherapeutics announced a significant increase in revenue for the quarter ended June 30, 2026, driven by strong sales of Amtagvi and Proleukin, though net losses persist.
NASDAQ
Delcath Systems, Inc. announced its second quarter 2026 financial results, showcasing a significant increase in product revenue driven by HEPZATO sales and positive developments in ongoing clinical trials.
NASDAQ
Airship AI Holdings, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a significant increase in net revenues driven by commercial orders, though operating losses and accumulated deficit remain substantial.
NASDAQ
Satellogic Inc. reported a significant increase in revenue for the second quarter of 2026, driven by growth in both its Data & Analytics and Space Systems segments, but also experienced a substantial widening of its net loss.
NYSE
Resolute Holdings Management, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing strong revenue growth driven by the Husky acquisition and organic increases at CompoSecure, alongside significant debt financing.
NASDAQ
Aclarion, Inc. reported Q2 2026 results showing increased revenue driven by UK market growth, but also a substantial rise in operating expenses, leading to a wider net loss.
NYSE
Loar Holdings Inc. announced a significant increase in net sales for the second quarter of 2026, driven by strategic acquisitions and organic growth, despite higher interest expenses impacting profitability.
NYSE
SM Energy Company's Q2 2026 Form 10-Q filing reveals substantial revenue growth and net income, largely attributed to the successful integration of Civitas Resources and strategic divestitures.
NYSE
Evolent Health, Inc. announced its second quarter 2026 financial results, showing a substantial increase in revenue but also a significant rise in operating expenses and a wider net loss.
NASDAQ
Forrester Research, Inc. (FORR) reported a 10% year-over-year decrease in total revenues for the second quarter of 2026, alongside a significant goodwill impairment charge.
NASDAQ
Kulicke and Soffa Industries, Inc. (KLIC) reported a significant increase in net revenue for the third quarter of fiscal year 2026, driven by higher volumes across most segments, alongside improved gross profit margins.
NASDAQ
Celsius Holdings reported a significant revenue increase in Q2 2026, driven by its Alani Nu and Rockstar acquisitions, while managing increased operational costs and ongoing litigation.
NYSE
White Mountains Insurance Group reported a 4% increase in book value per share for Q2 2026, driven by strong operating company results and solid investment returns.
NYSE
Molson Coors Beverage Company reported a challenging second quarter for 2026, with net sales down 3.3% driven by a 5.4% decrease in financial volume, though improved pricing and sales mix provided some offset.
NASDAQ
Barinthus Biotherapeutics plc announced its second-quarter 2026 financial results, highlighting reduced operating expenses but continued net losses and a precarious Nasdaq listing status.
NASDAQ
CG Oncology, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, detailing increased operating expenses and net losses, alongside substantial cash reserves and ongoing clinical development for its bladder cancer treatment.
NASDAQ
Privia Health Group, Inc. announced significant revenue increases and improved operating income for the second quarter of 2026, driven by FFS patient care and value-based care initiatives.